Literature DB >> 9434785

Telomerase activity in human leukemic cell lines is inhibited by antisense pentadecadeoxynucleotides targeted against c-myc mRNA.

K Fujimoto1, M Takahashi.   

Abstract

Telomerase is a ribonucleoprotein complex that is thought to add telomeric repeats to the ends of chromosomes during the replicative phase of the cell cycle. We tested the hypothesis that proto-oncogene c-myc plays an essential role in the regulation of telomerase activity in vertebrate cells by exposing three human leukemic cell lines, HL60, U937, and K562, to 15-mer antisense c-myc oligonucleotides. All the treated cells showed a profound decrease in telomerase activity after c-myc antisense oligomer treatment, whereas cells treated with c-myc sense oligomers showed essentially no change in telomerase activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9434785     DOI: 10.1006/bbrc.1997.7806

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  Complex regulation of telomerase activity: implications for cancer therapy.

Authors:  K S Elenitoba-Johnson
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

2.  Effects of combined siRNA-TR and -TERT on telomerase activity and growth of bladder transitional cell cancer BIU-87 cells.

Authors:  Wen Cheng; Zhifeng Wei; Jianping Gao; Zhengyu Zhang; Jingping Ge; Kangzhen Jing; Feng Xu; Peng Xie
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-06-17

3.  Telomerase is regulated by protein kinase C-zeta in human nasopharyngeal cancer cells.

Authors:  C C Yu; S C Lo; T C Wang
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

4.  TERT Genetic Mutations as Prognostic Marker in Glioma.

Authors:  Peiliang Geng; Xiaoxin Zhao; Juanjuan Ou; Jianjun Li; Rina Sa; Houjie Liang
Journal:  Mol Neurobiol       Date:  2016-05-20       Impact factor: 5.590

5.  Decrease in telomerase activity in U-87MG human glioblastomas after treatment with an antagonist of growth hormone-releasing hormone.

Authors:  H Kiaris; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-05       Impact factor: 11.205

6.  MYC drives overexpression of telomerase RNA (hTR/TERC) in prostate cancer.

Authors:  Javier A Baena-Del Valle; Qizhi Zheng; David M Esopi; Michael Rubenstein; Gretchen K Hubbard; Maria C Moncaliano; Andrew Hruszkewycz; Ajay Vaghasia; Srinivasan Yegnasubramanian; Sarah J Wheelan; Alan K Meeker; Christopher M Heaphy; Mindy K Graham; Angelo M De Marzo
Journal:  J Pathol       Date:  2017-11-14       Impact factor: 7.996

7.  miR-101 sensitizes K562 cell line to imatinib through Jak2 downregulation and inhibition of NF-κB target genes.

Authors:  Elham Farhadi; Farhad Zaker; Majid Safa; Mohammad Reza Rezvani
Journal:  Tumour Biol       Date:  2016-08-12

8.  The regulation of telomerase in oncogenesis.

Authors:  D A Skvortzov; M P Rubzova; M E Zvereva; F L Kiselev; O A Donzova
Journal:  Acta Naturae       Date:  2009-04       Impact factor: 1.845

9.  Telomerase activity of the Lugol-stained and -unstained squamous epithelia in the process of oesophageal carcinogenesis.

Authors:  M Inai; M Kano; Y Shimada; T Sakurai; T Chiba; M Imamura
Journal:  Br J Cancer       Date:  2001-09-28       Impact factor: 7.640

Review 10.  Modulation of Telomerase Activity in Cancer Cells by Dietary Compounds: A Review.

Authors:  Takahiro Eitsuka; Kiyotaka Nakagawa; Shunji Kato; Junya Ito; Yurika Otoki; Soo Takasu; Naoki Shimizu; Takumi Takahashi; Teruo Miyazawa
Journal:  Int J Mol Sci       Date:  2018-02-06       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.